ACSL4 knockout downregulated lipid peroxidation and inhibited ACSL4/p38 MAPK/GPX4 pathway-mediated ferroptosis, ultimately inhibiting NAFLD progression [194]. Here, ACSL4 is linked to metabolic dysfunction-associated steatotic liver disease.